Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01336881 · ClinicalTrials.gov registry record
Biomarkers in Tissue Samples From Young Patients With Liver Cancer
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 99
- Enrollment target
NCT01336881 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 99 participants.
The verdict
NCT01336881 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
This research trial is studying biomarkers in tissue samples from young patients with liver cancer. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
Interventions
- GENETIC gene expression analysis
- GENETIC microarray analysis
- GENETIC RNA analysis
- OTHER diagnostic laboratory biomarker analysis
- GENETIC nucleic acid sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01336881
The ClinicalTrials.gov registry entry for NCT01336881 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT01336881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01336881 about?
NCT01336881 is a clinical study titled "Biomarkers in Tissue Samples From Young Patients With Liver Cancer". This research trial is studying biomarkers in tissue samples from young patients with liver cancer. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
What is the current status of trial NCT01336881?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2011-04.
What interventions are being tested in trial NCT01336881?
The interventions under investigation include: gene expression analysis (GENETIC), microarray analysis (GENETIC), RNA analysis (GENETIC), diagnostic laboratory biomarker analysis (OTHER), nucleic acid sequencing (GENETIC).
Who is sponsoring clinical trial NCT01336881?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.